Rare diseases
Investigational molecules
Locations
Back to Germany968 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
GermanyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GermanyStudy of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
GermanyStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
GermanyStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
GermanyLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
GermanyComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
GermanyStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
